Inflammasome

An inflammasome is a cytosolic, supramolecular multiprotein signaling complex that assembles in myeloid leukocytes (macrophages, dendritic cells, and neutrophils) and barrier epithelial cells in response to intracellular pathogen-associated molecular patterns (PAMPs) or sterile damage-associated molecular patterns (DAMPs), serving as the molecular scaffold for the proximity-induced activation of inflammatory caspase-1. Discovered and named in 2002 by Jürg Tschopp, Fabio Martinon, and Kimberly Burns at the University of Lausanne, the inflammasome integrates cytosolic surveillance into acute inflammation and antimicrobial defense across vertebrate immunology.

Upon activation, a canonical inflammasome polymerizes into a single micron-scale perinuclear structure (~0.8–1.2 μm in diameter) termed the ASC speck. Active caspase-1 within this platform executes two concerted proteolytic events: (1) it cleaves the biologically inactive cytokine precursors pro-interleukin-1β (pro-IL-1β, 31 kDa) and pro-interleukin-18 (pro-IL-18, 24 kDa) into their mature, secreted pro-inflammatory forms (IL-1β, 17 kDa—the body's primary endogenous pyrogen—and IL-18, 18 kDa), and (2) it cleaves the pore-forming executioner protein Gasdermin D (GSDMD), whose N-terminal domain perforates the plasma membrane to release IL-1β/IL-18 and induce lytic, pro-inflammatory cell death termed pyroptosis.

Sensor, ASC Adaptor, and Pro-Caspase-1 Polymerization

Canonical inflammasomes share a conserved tripartite modular architecture assembled through homotypic interactions among members of the Death-Fold Domain superfamily—specifically Pyrin Domains (PYDs) and Caspase Activation and Recruitment Domains (CARDs):

1. Cytosolic Pattern-Recognition Sensor: An oligomeric receptor belonging to the NLR (Nucleotide-binding oligomerization domain, Leucine-rich Repeat-containing) family, the ALR (AIM2-Like Receptor) family, or Pyrin (TRIM20). NLR sensors contain an N-terminal effector domain (PYD in NLRPs; CARD in NLRCs), a central NACHT (NOD) ATPase domain that mediates ATP-dependent oligomerization into wheel-like or helical assemblies, and C-terminal leucine-rich repeats (LRRs) involved in autoinhibition and ligand sensing.
2. The Bipartite Adaptor Protein ASC (PYCARD): A 22-kDa adaptor protein composed of an N-terminal PYD linked by a flexible hinge to a C-terminal CARD. When an activated sensor presents clustered PYDs, ASC monomers nucleate via homotypic PYD–PYD interactions into helical prion-like filaments, displaying a dense outer coat of CARDs that condense into the micron-sized ASC speck near the centrosome. (Sensors that already possess a CARD, such as NLRC4 and NLRP1, can recruit pro-caspase-1 directly via CARD–CARD interactions, though ASC amplifies their proteolytic output by ~10- to 50-fold.)
3. The Effector Zymogen Pro-Caspase-1: A 45-kDa cysteine-aspartic protease containing an N-terminal CARD followed by large (p20) and small (p10) catalytic subunits. Recruited to the ASC speck via homotypic CARD–CARD filaments, high local density triggers proximity-induced autoproteolytic dimerization into active heterotetrameric (p20/p10)₂ caspase-1.

The Five Major Canonical Sensors and Non-Canonical Caspase-4/5/11

Mammalian cells express several distinct inflammasome sensors, each tuned to a specific microbial virulence activity or cellular perturbation:

• NLRP3 (Cryopyrin): The most versatile and clinically implicated sensor. Rather than binding a single ligand directly, NLRP3 senses a common downstream cellular homeostasis perturbation triggered by diverse stimuli—most notably potassium (K⁺) efflux across the plasma membrane.
• NLRC4 (coupled with NAIPs): NAIP (NLR family, Apoptosis Inhibitory Protein) sensors (human NAIP; murine NAIP1, NAIP2, and NAIP5/6) bind directly to cytosolic bacterial flagellin or the inner rod and needle proteins of Type III and Type IV bacterial secretion systems (from Salmonella, Shigella, Legionella, and Pseudomonas). A single ligand-bound NAIP protomer nucleates the cooperative polymerization of 10–11 NLRC4 subunits into a disk-shaped 11- to 12-mer wheel.
• AIM2 (Absent in Melanoma 2): A non-NLR sensor composed of a C-terminal positively charged HIN-200 domain that binds directly to the sugar-phosphate backbone of cytosolic double-stranded DNA (dsDNA, minimum length ~70–80 bp) in a sequence-independent manner (detecting cytosolic DNA viruses like vaccinia and cytomegalovirus, Francisella tularensis, or leaked host nuclear/mitochondrial DNA) and an N-terminal PYD that nucleates ASC.
• NLRP1: Possesses a unique C-terminal FIIND (Function-to-Find Domain) that undergoes constitutive autoproteolysis, followed by a C-terminal CARD. When bacterial toxins (such as Bacillus anthracis lethal factor protease) or viral 3C proteases cleave the N-terminal fragment of NLRP1, the N-terminus is degraded by the N-end rule proteasome ("functional degradation"), liberating the non-covalently bound C-terminal UPA–CARD fragment to oligomerize and activate caspase-1.
• Pyrin (MEFV / TRIM20): Functions as a "guard" receptor that monitors the activity of host RhoA GTPase. When bacterial toxins (such as Clostridioides difficile TcdA/TcdB, Burkholderia cenocepacia TecA, or Yersinia YopE/YopT) glucosylate, deamidate, or ribosylate RhoA, loss of PKN1/PKN2 kinase activity dephosphorylates Pyrin at Ser208/Ser242, releasing inhibitory 14-3-3 proteins and triggering Pyrin–ASC inflammasome assembly.
• Non-Canonical Inflammasome (Human Caspase-4/5; Murine Caspase-11): Intracellular Gram-negative bacterial lipopolysaccharide (LPS — specifically hexa-acylated Lipid A) released into the cytosol from vacuolar bacteria (via interferon-inducible guanylate-binding proteins [GBPs]) binds directly to the CARD of caspase-4 and caspase-5 (or murine caspase-11). Oligomerized caspase-4/5/11 directly cleaves Gasdermin D to induce pyroptosis, while K⁺ efflux through the resulting GSDMD pores secondarily activates the canonical NLRP3 inflammasome to mature IL-1β.

Signal 1 (Priming) and Signal 2 (Activation and NEK7 Binding)

Because accidental activation of NLRP3 would trigger systemic tissue destruction, resting macrophages enforce a strict two-signal checkpoint for canonical NLRP3 inflammasome assembly:

1. Signal 1 — Transcriptional and Post-Translational Priming: Resting macrophages express negligible levels of pro-IL-1β and insufficient NLRP3. Engagement of cell-surface Toll-like receptors (e.g., TLR4 by LPS), NOD2, or cytokine receptors (TNFR, IL-1R) activates the transcription factor NF-κB, driving robust de novo transcription of NLRP3 and IL1B mRNA. Concurrently, Signal 1 induces rapid post-translational licensing of NLRP3 via deubiquitination by the JAMM-domain metalloprotease BRCC3 and phosphorylation by JNK1.
2. Signal 2 — Oligomerization and the K⁺ Efflux Convergence: A second stimulus triggers the conformational transition of primed NLRP3 from an inactive cage into an active 10-mer or 12-mer disk Bound at its LRR domain by the mitotic centrosomal kinase NEK7. Signal 2 agonists converge on three principal cellular pathways:

• Ionic Flux (Potassium Efflux): Extracellular ATP released by necrotic cells gates the purinergic P2X₇ cation channel in collaboration with the two-pore domain K⁺ channel TWIK2; bacterial pore-forming toxins (nigericin, α-hemolysin, listeriolysin O) or complement membrane attack complexes similarly drop intracellular [K⁺] from ~140 mM below the threshold of ~90 mM, which is both necessary and sufficient to activate NLRP3.
• Lysosomal Rupture by Crystalline Particulates: Phagocytosis of indigestible crystalline DAMPs or environmental particulates—including monosodium urate (MSU) crystals (the causative agent of gout), calcium pyrophosphate dihydrate (CPPD, pseudogout), cholesterol crystals in atherosclerotic plaques, amyloid-β fibrils, silica, and asbestos—mechanically ruptures phagolysosomes, releasing cathepsin B/L into the cytosol and triggering K⁺ efflux.
• Mitochondrial Dysfunction and ROS: Mitochondrial reactive oxygen species (mtROS), externalized mitochondrial cardiolipin, and oxidized mitochondrial DNA (ox-mtDNA) synthesized via CMPK2 and released through VDAC/mPTP pores directly bind and activate NLRP3.

Gasdermin D Cleavage and Pyroptotic Pore Formation

The discovery in 2015 by Feng Shao and Vishva Dixit of Gasdermin D (GSDMD, ~53 kDa) resolved how inflammasomes execute lytic cell death (pyroptosis) and secrete leaderless cytokines (IL-1β and IL-18 lack an N-terminal endoplasmic reticulum signal peptide and cannot exit via the classical ER–Golgi secretory pathway). Full-length GSDMD consists of a pore-forming N-terminal domain (GSDMD-NT, ~31 kDa) held inactive by an autoinhibitory C-terminal domain (GSDMD-CT, ~22 kDa) connected via a flexible linker.

Active caspase-1 (or non-canonical caspase-4/5/11) cleaves human GSDMD after Asp275 (Asp276 in mice) within the interdomain linker. Liberated GSDMD-NT binds with high specificity to acidic phospholipids confined to the inner leaflet of the mammalian plasma membrane (phosphatidylinositol 4,5-bisphosphate [PIP₂] and phosphatidylserine)—as well as cardiolipin in bacterial and mitochondrial membranes—while sparing the outer leaflet of neighboring bystander host cells (which lacks acidic phospholipids). Within the membrane, 31 to 34 GSDMD-NT protomers oligomerize into a transmembrane β-barrel ring pore with an inner diameter of 18 to 21.5 nm. Because the pore lumen is lined with negatively charged glutamate/aspartate patches, it acts as an electrostatic filter that selectively repels negatively charged pro-IL-1β while permitting rapid passage of mature, neutral/positively charged IL-1β and IL-18 (~4.5 nm diameter) even in living, non-lysed "hyperactive" macrophages and dendritic cells. If pore density exceeds ESCRT-III membrane repair capacity, osmotic water influx swells the cell, and the transmembrane protein NINJ1 (Ninjurin-1) oligomerizes to rupture the plasma membrane completely, releasing large alarmins such as HMGB1 and lactate dehydrogenase (LDH).

Dysregulated inflammasome activation drives both rare monogenic autoinflammatory syndromes and prevalent metabolic diseases:

• Cryopyrin-Associated Periodic Syndromes (CAPS): Autosomal dominant gain-of-function point mutations in the NACHT domain of NLRP3 (disrupting ADP-mediated autoinhibition so Signal 1 alone triggers constitutive inflammasome assembly without Signal 2) cause a continuum of autoinflammatory diseases: Familial Cold Autoinflammatory Syndrome (FCAS), Muckle–Wells Syndrome (MWS) (recurrent fever, urticaria, sensorineural deafness, and AA amyloidosis), and Neonatal-Onset Multisystem Inflammatory Disease (NOMID / CINCA). CAPS responds dramatically to targeted IL-1 blockade using anakinra (recombinant IL-1 receptor antagonist), canakinumab (neutralizing anti-IL-1β monoclonal antibody), or rilonacept.
• Crystal Arthropathies and Cardiometabolic Disease: In acute gout, articular macrophages phagocytose monosodium urate (MSU) needles and activate the NLRP3 inflammasome (treated clinically with colchicine, which depolymerizes microtubules to block spatial transport of ASC to mitochondrial NLRP3). In atherosclerosis, intimal macrophages engulfing oxidized LDL nucleate intracellular cholesterol crystals that trigger NLRP3-dependent IL-1β secretion; the landmark CANTOS Phase III clinical trial demonstrated that neutralizing IL-1β with canakinumab significantly reduced recurrent cardiovascular events (myocardial infarction and stroke) independently of lipid lowering.

How does pyroptosis differ mechanistically and immunologically from apoptosis?

Apoptosis (driven by initiator caspases-8/9 and executioner caspases-3/7) is an immunologically silent or tolerogenic program characterized by cytoplasmic shrinkage, chromatin condensation, nuclear fragmentation, and intact plasma membrane blebbing into phosphatidylserine-displaying apoptotic bodies that are cleared quietly by phagocytes. Pyroptosis (driven by inflammatory caspases-1/4/5/11 and Gasdermin D 18–21 nm pores) is an intensely pro-inflammatory, lytic form of programmed cell death characterized by osmotic cell swelling, NINJ1-mediated plasma membrane rupture, and explosive release of mature IL-1β, IL-18, and DAMPs (ATP, HMGB1) that recruit neutrophils to the site of infection.

Why can't IL-1beta be secreted directly after TLR4 stimulation without inflammasome activation?

Unlike TNF-α or IL-6, which possess an N-terminal hydrophobic signal peptide that directs their nascent polypeptides into the rough endoplasmic reticulum for immediate constitutive secretion via the Golgi apparatus, pro-IL-1β (31 kDa) is synthesized on free cytosolic ribosomes as a leaderless precursor that is biologically inactive (unable to bind the IL-1 receptor) and carries an acidic N-terminal pro-domain. It requires Signal 2 inflammasome activation of caspase-1 both to cleave off the inhibitory pro-domain (generating bioactive 17-kDa IL-1β) and to cleave Gasdermin D to form the plasma membrane conduit through which mature IL-1β exits the cytosol.

Why do Gasdermin D pores kill the infected macrophage from the inside out without lysing healthy neighboring host cells after release?

The N-terminal pore-forming domain of Gasdermin D (GSDMD-NT) requires negatively charged phospholipids—specifically phosphoinositides (PIP₂, PIP₃) and phosphatidylserine—to bind and insert into a lipid bilayer. In healthy mammalian cells, flippase enzymes restrict PIP₂ and phosphatidylserine strictly to the cytoplasmic (inner) leaflet of the plasma membrane, whereas the extracellular (outer) leaflet is composed of neutral phosphatidylcholine and sphingomyelin. Consequently, GSDMD-NT can only perforate the host cell membrane from the cytosolic side (while also lysing phagocytosed bacteria whose membranes contain cardiolipin), leaving intact bystander cells unharmed.

1. Martinon, F., Burns, K., & Tschopp, J. (2002). "The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β." Molecular Cell, 10(2), 417–426. https://doi.org/10.1016/S1097-2765(02)00599-300599-3)
2. Shi, J., Zhao, Y., Wang, K., et al. (2015). "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death." Nature, 526(7575), 660–665. https://doi.org/10.1038/nature15514
3. Broz, P., & Dixit, V. M. (2016). "Inflammasomes: mechanism of assembly, regulation and signalling." Nature Reviews Immunology, 16(7), 407–420. https://doi.org/10.1038/nri.2016.58
4. Swanson, K. V., Deng, M., & Ting, J. P. Y. (2019). "The NLRP3 inflammasome: molecular activation and regulation to therapeutics." Nature Reviews Immunology, 19(8), 477–489. https://doi.org/10.1038/s41577-019-0165-0